MATERIALS AND METHODS: Bioanalytical Method Development Bioanalytical method development is the process of creating and optimizing a procedure to identify and quantify an analyte (drug) in human plasma
GLP-1, like any drug, can have side effects
NICE guidance recommends GLP-1 receptor agonists as treatment options for type 2 diabetes in specific circumstances, typically when other medications have not achieved adequate glycaemic control or when weight loss would provide additional benefit
It encourages people to prioritize healthy food and physical activity especially weight training while taking the medication
This is when nausea peaks for most patients, and introducing alcohol during this window significantly increases your risk of severe nausea, vomiting, and dehydration
Available online: 2.Fisher R.S., Acevedo C., Arzimanoglou A., Bogacz A., Cross J.H., Elger C.E., Engel J., Jr., Forsgren L., French J.A., Glynn M., et al